Peter Thall

19PUBLICATIONS
72CO-AUTHORS
Haematological tumoursNanomedicineTissue engineeringCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 31, 2026
Phase I/II Trial of Evomela for Autologous Transplant in Myeloma: Schedule Optimization and Matched Comparison with MEL200.

|Jul 05, 2026
Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells.

|Apr 20, 2026
BAR12: Bayesian Autoregressive Phase 1-2 Design for Cell Therapy Trials With Manufacturing Changes.

|Aug 25, 2025
High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors.

Yago Nieto, John F Ward, Wayne Hofstetter

|Jun 26, 2025
Practical Bayesian Guidelines for Small Randomized Oncology Trials.

Peter F Thall

|Jan 13, 2025
Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma.

Yago Nieto, Jeremy Ramdial, Benigno Valdez

Pageof 4

Frequent Collaborators

4 joint publications

Ying Yuan

3 joint publications

Uday R Popat

3 joint publications

Yago Nieto

3 joint publications

Pavlos Msaouel